| AS03-and MF59-adjuvanted influenza vaccines in children AL Wilkins, D Kazmin, G Napolitani, EA Clutterbuck, B Pulendran, ... Frontiers in immunology 8, 1760, 2017 | 124 | 2017 |
| Toxic shock syndrome–the seven Rs of management and treatment AL Wilkins, AC Steer, PR Smeesters, N Curtis Journal of Infection 74, S147-S152, 2017 | 83 | 2017 |
| Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg? AL Wilkins, AC Steer, N Cranswick, A Gwee Archives of disease in childhood 103 (5), 514-519, 2018 | 41 | 2018 |
| Emerging clinical experience with vaccines against group B meningococcal disease AL Wilkins, MD Snape Vaccine 36 (36), 5470-5476, 2018 | 30 | 2018 |
| Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children D Kazmin, EA Clutterbuck, G Napolitani, AL Wilkins, A Tarlton, ... npj Vaccines 8 (1), 100, 2023 | | 2023 |
| Individualized vancomycin dosing in infants: prospective evaluation of an online dose calculator AL Wilkins, T Lai, X Zhu, S Bolisetty, R Chiletti, N Cranswick, K Gardiner, ... International Journal of Antimicrobial Agents, 106728, 2023 | | 2023 |
